Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02852798
What this trial is testing

Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC

Who this might be right for
Nonsquamous Nonsmall Cell Neoplasm of Lung
Jiangsu ShengDiYa Medicine Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT04253873
What this trial is testing

Clinical Study of Apatinib Combined With Temozolomide in the Treatment of Uncontrolled or Repeated High-grade Gliomas

Who this might be right for
High-grade Gliomas
WuHui 40
Testing effectiveness (Phase 2)UnknownNCT04067986
What this trial is testing

Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer

Who this might be right for
Colorectal Cancer Recurrent
Zhongshan Hospital Xiamen University 62
Large-scale testing (Phase 3)UnknownNCT03428022
What this trial is testing

Apatinib Combined With EGFR-TKI for Advanced Slow-progressed EGFR-TKI Resistant NSCLC

Who this might be right for
NSCLCApatinibEGFR-TKI
Shenzhen People's Hospital 54
Early research (Phase 1)UnknownNCT03276156
What this trial is testing

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 12
Testing effectiveness (Phase 2)Study completedNCT03816553
What this trial is testing

SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical Cancer
Sun Yat-sen University 45
Testing effectiveness (Phase 2)UnknownNCT02942329
What this trial is testing

Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer

Who this might be right for
Gastric CancerHepatocellular Carcinoma
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT04720131
What this trial is testing

Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.

Who this might be right for
Biliary Tract CancerAnti-PD-1 TherapyTargeted Molecular Therapy+1 more
Beijing Friendship Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06831175
What this trial is testing

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Who this might be right for
Adrenal Cortical CarcinomaAdrenal Cortical CancerAdrenal Cancer
West China Hospital 28
Testing effectiveness (Phase 2)UnknownNCT03393507
What this trial is testing

Apatinib Treatment in for Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapeutic Toxicity
The People's Hospital of Leshan 34
Testing effectiveness (Phase 2)UnknownNCT03707639
What this trial is testing

Study of the Combination of Apatinib and POF

Who this might be right for
Gastric Adenocarcinoma
Fujian Cancer Hospital 26
Testing effectiveness (Phase 2)Study completedNCT05025033
What this trial is testing

Chemotherapy Combined With Apatinib and PD-1 Antibody

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT06464614
What this trial is testing

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology 54
Testing effectiveness (Phase 2)UnknownNCT04440917
What this trial is testing

Camrelizumab Combined With Apatinib Mesylate for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 32
Testing effectiveness (Phase 2)UnknownNCT03144843
What this trial is testing

Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Sun Yat-sen University 110
Not applicableEnded earlyNCT07000344
What this trial is testing

Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP Inhibitor

Who this might be right for
Ovarian Cancer
Peking Union Medical College Hospital 5
Testing effectiveness (Phase 2)UnknownNCT05189184
What this trial is testing

Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06339216
What this trial is testing

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04724226
What this trial is testing

Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT03982485
What this trial is testing

Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
RenJi Hospital 196
Next Page